港亞控股(01723.HK)中期純利增長256%至1554.3萬港元
格隆匯11月28日丨港亞控股(01723.HK)發佈中期業績,截至2019年9月30日止6個月,公司實現收益1.04億港元,同比增長2.3%;毛利3548.1萬港元,同比增長3.7%;公司擁有人應占期內溢利1554.3萬港元,同比增長256%;基本每股盈利3.89港仙;不派息。
公告表示,回顧該期間,集團的收益相對穩定,較2018年同期輕微增加約2.3%。收益增加主要由於向集團銷售網絡內的批發商及零售商的銷售額增加約1520萬港元,抵銷集團自營零售店的銷售額減少約1290萬港元的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.